Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phase-Reference-Cited by-同舟云学术

Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phase

Published:2014-11-04 Issue:5 Volume:141 Page:887-899
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Machova Polakova Katerina,Kulvait Vojtech,Benesova Adela,Linhartova Jana,Klamova Hana,Jaruskova Monika,de Benedittis Caterina,Haferlach Torsten,Baccarani Michele,Martinelli Giovanni,Stopka Tomas,Ernst Thomas,Hochhaus Andreas,Kohlmann Alexander,Soverini Simona

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00432-014-1845-6.pdf

Reference15 articles.

1. Baccarani M, Deininger MW, Rosti G, Hochhaus A, Soverini S, Apperley JF et al (2013) European LeukemiaNet recommendations for the management of chronic myeloid leukemia. Blood 122:872–874

2. Bracho MA, Moya A, Barrio E (1998) Contribution of Taq polymerase-induced errors to the estimation of RNA virus diversity. J Gen Virol 79:2921–2928

3. Campbell PJ, Pleasance ED, Stephens PJ, Dicks E, Rance R, Goodhead I et al (2008) Subclonal phylogenetic structures in cancer revealed by ultra-deep sequencing. PNAS 105:13081–13086

4. Gorre ME, Mohammed M, Ellwood K, Hsu N, Paquette R, Rao PN et al (2001) Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 293:876–880

5. Grossmann V, Roller A, Klein HU, Weissmann S, Kern W, Haferlach C et al (2013) Robustness of amplicon deep sequencing underlines its utility in clinical applications. J Mol Diagn 15:473–484

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic options for chronic myeloid leukemia following the failure of second-generation tyrosine kinase inhibitor therapy;Frontiers in Oncology;2024-07-29

2. Validation of a novel NGS based BCR::ABL1 kinase domain mutation detection assay in Indian cohort;Scientific Reports;2024-07-08

3. Significance of Somatic Mutation Profiling in CML Beyond BCR-ABL: A Retrospective Study of the Indian Population;Indian Journal of Hematology and Blood Transfusion;2024-06-21

4. Resistance mutations in CML and how we approach them;Hematology;2023-12-08

5. Disease Response Assessment Modalities in Chronic Myeloid Leukemia: Past, Present, and Future;Indian Journal of Medical and Paediatric Oncology;2023-11-27